Overall Status

Active, not recruiting (2)

Suspended (1)

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

City of Hope Medical Center (1)

Mayo Clinic (1)

Southwest Oncology Group (1)

Collaborator

National Cancer Institute (NCI) (3)

National Comprehensive Cancer Network (1)

Intervention

cisplatin (2)

nab-paclitaxel (2)

gemcitabine (1)

gemcitabine hydrochloride (1)

irinotecan (1)

irinotecan hydrochloride (1)

quality-of-life assessment (1)

questionnaire administration (1)

trifluridine and tipiracil hydrochloride (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

stage ivb gallbladder cancer ajcc v8

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting

Has Results

Advanced Bile Duct Carcinoma
+17 more

Irinotecan
+2 more

Rochester, Minnesota

Mayo Clinic

Jan 5, 2023

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended

Distal Bile Duct Adenocarcinoma
+7 more

Cisplatin
+4 more

Duarte, California

City of Hope Medical Center

Dec 8, 2022

Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC

Active, not recruiting

Stage III Distal Bile Duct Cancer AJCC v8
+16 more

Cisplatin
+2 more

Anchorage, Alaska
+691 more

Oct 8, 2021